发明名称 |
USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS |
摘要 |
This disclosure provides a method for treating glioma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating glioma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) antibody and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody. |
申请公布号 |
WO2016100561(A3) |
申请公布日期 |
2016.08.18 |
申请号 |
WO2015US66177 |
申请日期 |
2015.12.16 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
CORIC, Vladimir;CHENG, Shinta |
分类号 |
A61K39/395;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|